سعر مالتي ريلاكس 10مجم 20 قرص 2024

Multi-relax 10 mg film-coated tablets (Multi-Apex): cyclobenzaprine centrally acting skeletal muscle relaxant, 20 tablets.

• Adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions; short-term use only (up to 2-3 weeks). Not effective for spasticity from cerebral or spinal cord disease or in children with cerebral palsy.Population: Adults and adolescents 15 years and olderDailyMed (U.S. National Library of Medicine)

• Most common in controlled trials with 10 mg: drowsiness (38%), dry mouth (32%), fatigue (6%) and headache (5%); dizziness is also frequently reported.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Reported in 1-3%: abdominal pain, acid regurgitation, constipation, diarrhoea, dizziness, nausea, irritability, decreased mental acuity, nervousness, upper respiratory infection and pharyngitis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component of the product.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant use of MAO inhibitors or within 14 days after their discontinuation (hyperpyretic crisis, seizures and deaths reported).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Acute recovery phase of myocardial infarction, arrhythmias, heart block or conduction disturbances, or congestive heart failure.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Serotonin syndrome has been reported when used with SSRIs, SNRIs, TCAs, tramadol, bupropion, meperidine, verapamil or MAO inhibitors; observe carefully if combined.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Atropine-like action: use with caution in patients with urinary retention, angle-closure glaucoma, increased intraocular pressure, or taking anticholinergic medicines.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• May impair mental and/or physical abilities needed for driving or operating machinery, especially with alcohol or other CNS depressants.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• MAO inhibitorsLife-threatening interactions; concomitant use or use within 14 days is contraindicated.DailyMed (U.S. National Library of Medicine)
• Serotonergic drugs (SSRIs, SNRIs, TCAs, tramadol, bupropion, meperidine, verapamil)Risk of serotonin syndrome; careful observation if co-treatment is warranted.DailyMed (U.S. National Library of Medicine)
• Alcohol, barbiturates and other CNS depressantsEffects may be enhanced.DailyMed (U.S. National Library of Medicine)

• Animal reproduction studies (rats, mice, rabbits up to 20 times the human dose) showed no harm to the fetus; there are no adequate well-controlled studies in pregnant women; use in pregnancy only if clearly needed.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Not known whether excreted in human milk; because it is closely related to tricyclic antidepressants (some of which are excreted in milk), use caution in nursing women.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Cyclobenzaprine: Acts primarily within the CNS at the brain stem; reduces tonic somatic motor activity influencing both alpha and gamma motor systems (structurally related to tricyclic antidepressants).